Connection

JANET BUTEL to Polyomavirus Infections

This is a "connection" page, showing publications JANET BUTEL has written about Polyomavirus Infections.
Connection Strength

7.899
  1. SV40 seroprevalence in two Latin American countries involved in field trials of candidate oral poliovaccines. J Infect. 2019 06; 78(6):476-483.
    View in: PubMed
    Score: 0.603
  2. Neutralizing and IgG antibodies against simian virus 40 in healthy pregnant women in Italy. PLoS One. 2014; 9(10):e110700.
    View in: PubMed
    Score: 0.443
  3. Viral microRNA effects on pathogenesis of polyomavirus SV40 infections in syrian golden hamsters. PLoS Pathog. 2014 Feb; 10(2):e1003912.
    View in: PubMed
    Score: 0.422
  4. Ethnic differences in polyomavirus simian virus 40 seroprevalence among women in Houston, Texas. J Infect. 2013 Jan; 66(1):67-74.
    View in: PubMed
    Score: 0.382
  5. Polyomavirus JC urinary shedding in kidney and liver transplant recipients associated with reduced creatinine clearance. J Infect Dis. 2012 Sep 15; 206(6):875-80.
    View in: PubMed
    Score: 0.378
  6. Patterns of polyomavirus SV40 infections and associated cancers in humans: a model. Curr Opin Virol. 2012 Aug; 2(4):508-14.
    View in: PubMed
    Score: 0.378
  7. Lymphotropism of Merkel cell polyomavirus infection, Nova Scotia, Canada. Emerg Infect Dis. 2010 Nov; 16(11):1702-9.
    View in: PubMed
    Score: 0.336
  8. Variable frequency of polyomavirus SV40 and herpesvirus EBV in lymphomas from two different urban population groups in Houston, TX. J Clin Virol. 2009 Oct; 46(2):154-60.
    View in: PubMed
    Score: 0.308
  9. Polyomavirus shedding in the stool of healthy adults. J Clin Microbiol. 2009 Aug; 47(8):2388-91.
    View in: PubMed
    Score: 0.305
  10. Viral regulatory region effects on vertical transmission of polyomavirus SV40 in hamsters. Virology. 2009 Mar 30; 386(1):94-101.
    View in: PubMed
    Score: 0.298
  11. Quantification of vertical transmission of Murine polyoma virus by real-time quantitative PCR. J Gen Virol. 2005 Oct; 86(Pt 10):2721-2729.
    View in: PubMed
    Score: 0.236
  12. Frequent detection of polyomaviruses in stool samples from hospitalized children. J Infect Dis. 2005 Aug 15; 192(4):658-64.
    View in: PubMed
    Score: 0.233
  13. Effects of radiation and latent virus on immune responses in a space flight model. J Allergy Clin Immunol. 2005 Jun; 115(6):1297-303.
    View in: PubMed
    Score: 0.231
  14. Polyomavirus SV40 infections in Kazakhstan. J Infect. 2005 Feb; 50(2):142-8.
    View in: PubMed
    Score: 0.226
  15. Re: Lack of serologic evidence for prevalent simian virus 40 infection in humans. J Natl Cancer Inst. 2004 Apr 21; 96(8):633; author reply 633-4.
    View in: PubMed
    Score: 0.214
  16. SV40-positive brain tumor in scientist with risk of laboratory exposure to the virus. Oncogene. 2004 Mar 18; 23(12):2231-5.
    View in: PubMed
    Score: 0.212
  17. Simian virus 40 in human cancers. Am J Med. 2003 Jun 01; 114(8):675-84.
    View in: PubMed
    Score: 0.201
  18. Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy. AIDS. 2003 Apr 11; 17(6):801-7.
    View in: PubMed
    Score: 0.199
  19. Conventional epidemiology and the link between SV40 and human cancers. Lancet Oncol. 2003 Mar; 4(3):188-91.
    View in: PubMed
    Score: 0.198
  20. Polyomaviruses in kidney transplant recipients. Am J Transplant. 2002 May; 2(5):481.
    View in: PubMed
    Score: 0.186
  21. Detection of polyomavirus simian virus 40 tumor antigen DNA in AIDS-related systemic non-Hodgkin lymphoma. J Acquir Immune Defic Syndr. 2002 Feb 01; 29(2):109-16.
    View in: PubMed
    Score: 0.183
  22. Increasing evidence for involvement of SV40 in human cancer. Dis Markers. 2001; 17(3):167-72.
    View in: PubMed
    Score: 0.170
  23. Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst. 1999 Jan 20; 91(2):119-34.
    View in: PubMed
    Score: 0.149
  24. Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease. J Virol. 1998 May; 72(5):3980-90.
    View in: PubMed
    Score: 0.141
  25. Serological evidence of SV40 infections in HIV-infected and HIV-negative adults. J Med Virol. 1998 Apr; 54(4):276-84.
    View in: PubMed
    Score: 0.140
  26. Specific Antibodies Reacting with SV40 Large T Antigen Mimotopes in Serum Samples of Healthy Subjects. PLoS One. 2016; 11(1):e0145720.
    View in: PubMed
    Score: 0.120
  27. Fecal Polyomavirus Excretion in Infancy. J Pediatric Infect Dis Soc. 2016 Jun; 5(2):210-3.
    View in: PubMed
    Score: 0.111
  28. Naturally arising strains of polyomaviruses with severely attenuated microRNA expression. J Virol. 2014 Nov; 88(21):12683-93.
    View in: PubMed
    Score: 0.109
  29. A system for the analysis of BKV non-coding control regions: application to clinical isolates from an HIV/AIDS patient. Virology. 2010 Nov 25; 407(2):368-73.
    View in: PubMed
    Score: 0.083
  30. Polyomavirus infection and its impact on renal function and long-term outcomes after lung transplantation. Transplantation. 2009 Aug 15; 88(3):360-6.
    View in: PubMed
    Score: 0.077
  31. Detection of polyomavirus SV40 in tonsils from immunocompetent children. J Clin Virol. 2008 Sep; 43(1):66-72.
    View in: PubMed
    Score: 0.071
  32. SV40 multiple tissue infection and asbestos exposure in a hyperendemic area for malignant mesothelioma. Cancer Res. 2007 Sep 15; 67(18):8456-9.
    View in: PubMed
    Score: 0.068
  33. Polyomavirus SV40 and AIDS-related systemic non-Hodgkin's lymphoma. Cancer Treat Res. 2007; 133:215-40.
    View in: PubMed
    Score: 0.064
  34. A prospective longitudinal study of polyomavirus shedding in lung-transplant recipients. J Infect Dis. 2007 Feb 01; 195(3):442-9.
    View in: PubMed
    Score: 0.064
  35. Lymphoproliferative disorders in Costa Rica and simian virus 40. Haematologica. 2005 Dec; 90(12):1635-42.
    View in: PubMed
    Score: 0.060
  36. Emergent human pathogen simian virus 40 and its role in cancer. Clin Microbiol Rev. 2004 Jul; 17(3):495-508, table of contents.
    View in: PubMed
    Score: 0.054
  37. Polyomavirus simian virus 40 infection associated with nephropathy in a lung-transplant recipient. Transplantation. 2004 Apr 15; 77(7):1019-24.
    View in: PubMed
    Score: 0.053
  38. Re: Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst. 2003 May 07; 95(9):687; author reply 689.
    View in: PubMed
    Score: 0.050
  39. Association between SV40 and non-Hodgkin's lymphoma. Leuk Lymphoma. 2003; 44 Suppl 3:S33-9.
    View in: PubMed
    Score: 0.049
  40. Pathogenesis and management of polyomavirus infection in transplant recipients. Clin Infect Dis. 2002 Nov 01; 35(9):1081-7.
    View in: PubMed
    Score: 0.048
  41. Complete genomic sequence of a new Human polyomavirus 9 strain with an altered noncoding control region. Virus Genes. 2014 Dec; 49(3):490-2.
    View in: PubMed
    Score: 0.028
  42. Evidence of simian virus 40 exposure in a colony of captive baboons. Virology. 2008 Jul 20; 377(1):54-62.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.